Feasibility of CGM Use in Hospitalized Youth

Enrolling by invitation

Conditions studied: Hyperglycemia

In brief

This study is assessing the feasibility of a continuous glucose monitor during hospital admissions in youth and young adults with hyperglycemia due to diabetes or other underlying conditions that requires frequent glucose monitoring, through patient/family and nursing staff feedback on their perspectives and usability of the system in the hospital will be assessed through surveys. In addition, retrospective glycemic comparisons between CGM data and POC will be conducted.

Key facts

Study ID

NCT06143202

Run by

University of Colorado, Denver

People needed

120

Starts

2025-07-15

Expected to finish

2027-02-14

Last updated by the study team

2026-03-03

Who can join

Age: 2 and older, up to 26. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants will be 2 to less than 26 years of age at the time of enrollment.
• Participants will have a diagnosis of type 1 diabetes, type 2 diabetes, diabetes/hyperglycemia due to an underlying condition (such as in cystic fibrosis, monogenic diabetes), or medication induced diabetes/hyperglycemia (such as steroid-induced hyperglycemia or PEG-asparaginase induced hyperglycemia) and would benefit clinically from close glucose monitoring during hospitalization due to fluctuations in blood glucose values.
• Participant is expected to be in the hospital for longer than 12 hours after study enrollment with a goal of 36 hours or more as determined by study investigator or trained staff.
• Participant is willing to wear the continuous glucose monitor for the duration of the hospital admission or the lifespan of a continuous glucose monitor (7-14 days).

You may not qualify if…

• Has had a history of a significant skin reaction to the adhesives of a continuous glucose monitor in the past or concerns that one may occur due to underlying skin conditions (ie severe eczema, uncontrolled psoriasis, etc).
• Planned MRI or surgery during the study device use (can be enrolled pre or post procedure if sufficient time for sensor wear as determined by investigator [i.e. 24-48 before planned procedure]).
• Admission to inpatient psychiatry.
• Pregnancy.
• Currently using hydroxyurea.
• A condition that the investigator determines would prevent the patient from participation.

Where it is running

• University of California San Francisco — San Francisco, California, United States
• Stanford University — Stanford, California, United States
• University of Colorado, Barbara Davis Center — Aurora, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.